01/13/2025
4:02 PM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:08 PM | BeiGene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:02 AM | BeiGene (Filer)
| Form 10-K/A | |
01/07/2025
3:18 PM | BeiGene (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
5:05 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
4:02 PM | BeiGene (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:18 PM | BeiGene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/10/2024
8:25 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
8:30 PM | BAKER BROS. ADVISORS LP (Filed by)
BeiGene (Subject)
| Form SC 13D/A | |
12/10/2024
7:19 PM | BeiGene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:26 PM | BeiGene (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
5:02 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:48 PM | 667, L.P. (Reporting)
BeiGene (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024
8:48 PM | Baker Brothers Life Sciences LP (Reporting)
BeiGene (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
8:45 PM | BeiGene (Subject)
HHLR ADVISORS, LTD. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
3:31 PM | BeiGene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:23 PM | BeiGene (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:23 PM | BeiGene (Subject)
Wang Xiaodong (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
3:39 PM | BeiGene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
5:03 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:05 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
5:29 PM | BeiGene (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
| Form SC 13D/A | |
10/31/2024
4:40 PM | BeiGene (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
| Form SCHEDULE 13D/A | |
10/28/2024
5:05 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:48 PM | BeiGene (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:23 PM | BeiGene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:24 PM | BeiGene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
6:13 PM | BeiGene (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
6:16 PM | BeiGene (Issuer)
Sharp Shalini (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
6:21 PM | BeiGene (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
5:29 PM | BeiGene (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:27 PM | BeiGene (Subject)
Lee Chan Henry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
5:02 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
5:12 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
4:25 PM | BeiGene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:40 PM | BeiGene (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
4:40 PM | Ball Titus B. (Reporting)
BeiGene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
4:41 PM | BeiGene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:19 PM | BeiGene (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
6:29 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:30 PM | BeiGene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/14/2024
4:27 PM | BeiGene (Issuer)
Wang Xiaodong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:17 PM | BeiGene (Issuer)
Rosenberg Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:32 AM | BeiGene (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
08/07/2024
5:04 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
5:07 AM | BeiGene (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
4:06 PM | BeiGene (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
4:23 PM | BeiGene (Issuer)
Rosenberg Aaron (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
5:40 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
4:05 PM | BeiGene (Issuer)
Wang Julia Aijun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
3:18 PM | BeiGene (Subject)
Wang Julia Aijun (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
4:22 PM | BeiGene (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
4:24 PM | BeiGene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
4:25 PM | BeiGene (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
4:26 PM | BeiGene (Issuer)
Wang Julia Aijun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:30 PM | BeiGene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
3:19 PM | BeiGene (Subject)
Wang Julia Aijun (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
3:23 PM | BeiGene (Subject)
Wu Xiaobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
3:25 PM | BeiGene (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
4:27 PM | BeiGene (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:24 PM | BeiGene (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:25 PM | BeiGene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:25 PM | BeiGene (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:26 PM | BeiGene (Issuer)
Wang Julia Aijun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:50 PM | BeiGene (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
3:50 PM | BeiGene (Subject)
Wang Lai (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
3:53 PM | BeiGene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
3:57 PM | BeiGene (Subject)
Wang Julia Aijun (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
4:01 PM | BeiGene (Issuer)
BRANDICOURT OLIVIER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:02 PM | BeiGene (Issuer)
Dugan Margaret (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:03 PM | BeiGene (Issuer)
Lee Chan Henry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:03 PM | BeiGene (Issuer)
Wang Lai (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:04 PM | BeiGene (Issuer)
Wu Xiaobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:05 PM | Ball Titus B. (Reporting)
BeiGene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:31 PM | BeiGene (Issuer)
Yi Qingqing (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:23 PM | BeiGene (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2024
3:35 PM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:25 PM | BeiGene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
5:06 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
5:09 AM | BeiGene (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:21 PM | BeiGene (Filer)
| Form ARS | |
04/26/2024
3:16 PM | BeiGene (Filer)
| Form DEF 14A | |
04/26/2024
6:15 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:13 PM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:27 PM | BeiGene (Filer)
| Form PRE 14A | |
04/11/2024
5:01 PM | BeiGene (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:21 PM | BeiGene (Subject)
OYLER JOHN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024
4:26 PM | Ball Titus B. (Reporting)
BeiGene (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/20/2024
3:10 PM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
4:23 PM | BeiGene (Issuer)
OYLER JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
4:04 PM | BeiGene (Issuer)
Glazer Donald W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/08/2024
5:01 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
5:16 AM | BeiGene (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2024
5:02 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
3:12 PM | BeiGene (Subject)
OYLER JOHN (Filed by)
| Form SC 13G/A | |
01/23/2024
5:03 AM | BeiGene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free BGNE Stock Alerts